Gilead Hepatitis Elimination Webinar Series: Linkage to Care, Part 2 - PEAS (Tennessee, USA)

In the second part of the Linkage to Care episode, we focus on the work accomplished by Partnership to End AIDS Status (PEAS), an organization in the US that provides testing and services for hepatitis C and HIV, and outreach to the communities most impacted by the viruses.
Join Rosa Barber, Chief Operations Officer (PEAS) as she discusses the HepConnect Education workshops, which helps people at increased risk of hepatitis C to access care in the Memphis and Shelby County area of Tennessee.
For more information about PEAS, visit:
Website: www.partnershi...
LinkedIn: / partnership-to-end-aid...
Instagram: / partnershiptoendaidsst...
For more information about Gilead, visit:
Website: www.gilead.com
Stories@Gilead: stories.gilead...
Twitter: / gileadsciences
LinkedIn: / gileadsc. .
Instagram: / gileadsciences
Facebook: / gileadsciences
About Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
This webinar episode was created and fully funded by Gilead Sciences, Inc. GILEAD, the GILEAD logo, and the & design are trademarks of Gilead Sciences, Inc. © 2023 Gilead Sciences, Inc. All rights reserved.